{"id":"W2899283766","doi":"10.1182/blood-2018-99-111893","title":"Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Vinblastine; Internal medicine; Hazard ratio; Gastroenterology; Oncology; Confidence interval; Surgery; Chemotherapy; Vincristine; Lymphoma; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001620892,0.0003237595,0.0009187861,0.0001226869,0.0002153266,0.0008267739,0.0003662889,0.0004602627,0.001789666],"category_scores_gemma":[0.00104738,0.0001271676,0.001024664,0.0002537165,0.0002530145,0.0004973401,0.0002464102,0.001426238,0.0001520174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003527901,"about_ca_system_score_gemma":0.000434188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003287343,"about_ca_topic_score_gemma":0.001102859,"domain_scores_codex":[0.9994414,0.0003462301,0.00003497281,0.00007134229,0.0000422161,0.00006373795],"domain_scores_gemma":[0.9993199,0.0001866833,0.0002117853,0.00003756903,0.00003547174,0.0002084979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7475798,0.004608979,0.05002541,0.002178887,0.00539268,0.0004534369,0.00016117,0.00258363,0.007647546,0.0005716569,0.005607128,0.1731898],"study_design_scores_gemma":[0.5280651,0.2291727,0.2146397,0.000830726,0.00403153,0.001702976,0.0002092423,0.004389798,0.003317467,0.00227742,0.01128954,0.00007388528],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851925,0.01136482,0.0002798694,0.0003552547,0.0001534213,0.0002178848,0.0004605475,0.00002847095,0.001947342],"genre_scores_gemma":[0.9965525,0.001678051,0.0001729874,0.0004212847,0.0001052703,0.0001295023,0.0005462648,0.0000043523,0.0003898372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001789666,"threshold_uncertainty_score":0.008572161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0260380212226272,"score_gpt":0.3034584903612505,"score_spread":0.2774204691386233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}